Emergent BioSolutions (EBS) Tops Q1 EPS by 22c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.18 +0.49%
Revenue Growth %: +32.0%
Financial Fact:
Earnings per share - basic: 0.52
Today's EPS Names:
CCEL, SLP, TMQ, More
Revenue Growth %: +32.0%
Financial Fact:
Earnings per share - basic: 0.52
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.71, $0.22 better than the analyst estimate of $0.49. Revenue for the quarter came in at $222.2 million versus the consensus estimate of $279 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Wizz Air Holdings (WIZZ:LN) (WZZAF) to Underperform
- Fermi Inc. prices $375M convertible notes at 5% due 2031
- MakeMyTrip (MMYT) PT Raised to $65 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
